349 related articles for article (PubMed ID: 26200652)
1. Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome.
Vučković F; Krištić J; Gudelj I; Teruel M; Keser T; Pezer M; Pučić-Baković M; Štambuk J; Trbojević-Akmačić I; Barrios C; Pavić T; Menni C; Wang Y; Zhou Y; Cui L; Song H; Zeng Q; Guo X; Pons-Estel BA; McKeigue P; Leslie Patrick A; Gornik O; Spector TD; Harjaček M; Alarcon-Riquelme M; Molokhia M; Wang W; Lauc G
Arthritis Rheumatol; 2015 Nov; 67(11):2978-89. PubMed ID: 26200652
[TBL] [Abstract][Full Text] [Related]
2. IgG N-glycome changes during the course of severe COVID-19: An observational study.
Petrović T; Vijay A; Vučković F; Trbojević-Akmačić I; Ollivere BJ; Marjanović D; Bego T; Prnjavorac B; Đerek L; Markotić A; Lukšić I; Jurin I; Valdes AM; Hadžibegović I; Lauc G
EBioMedicine; 2022 Jul; 81():104101. PubMed ID: 35773089
[TBL] [Abstract][Full Text] [Related]
3. Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study.
Lu X; Wang L; Wang M; Li Y; Zhao Q; Shi Y; Zhang Y; Wang Y; Wang W; Ji L; Hou H; Li D
Front Immunol; 2023; 14():1257906. PubMed ID: 37809087
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the causal relationships between human IgG N-glycosylation and 12 common diseases associated with changes in the IgG N-glycome.
Zaytseva OO; Sharapov SZ; Perola M; Esko T; Landini A; Hayward C; Wilson JF; Lauc G; Aulchenko YS; Klarić L; Tsepilov YA
Hum Mol Genet; 2022 May; 31(10):1545-1559. PubMed ID: 34791244
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.
Trbojević Akmačić I; Ventham NT; Theodoratou E; Vučković F; Kennedy NA; Krištić J; Nimmo ER; Kalla R; Drummond H; Štambuk J; Dunlop MG; Novokmet M; Aulchenko Y; Gornik O; Campbell H; Pučić Baković M; Satsangi J; Lauc G;
Inflamm Bowel Dis; 2015 Jun; 21(6):1237-47. PubMed ID: 25895110
[TBL] [Abstract][Full Text] [Related]
6. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
[TBL] [Abstract][Full Text] [Related]
7. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
Lauc G; Huffman JE; Pučić M; Zgaga L; Adamczyk B; Mužinić A; Novokmet M; Polašek O; Gornik O; Krištić J; Keser T; Vitart V; Scheijen B; Uh HW; Molokhia M; Patrick AL; McKeigue P; Kolčić I; Lukić IK; Swann O; van Leeuwen FN; Ruhaak LR; Houwing-Duistermaat JJ; Slagboom PE; Beekman M; de Craen AJ; Deelder AM; Zeng Q; Wang W; Hastie ND; Gyllensten U; Wilson JF; Wuhrer M; Wright AF; Rudd PM; Hayward C; Aulchenko Y; Campbell H; Rudan I
PLoS Genet; 2013; 9(1):e1003225. PubMed ID: 23382691
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation of the
Klasić M; Markulin D; Vojta A; Samaržija I; Biruš I; Dobrinić P; Ventham NT; Trbojević-Akmačić I; Šimurina M; Štambuk J; Razdorov G; Kennedy NA; Satsangi J; Dias AM; Pinho S; Annese V; Latiano A; D'Inca R; ; Lauc G; Zoldoš V
Clin Epigenetics; 2018; 10():75. PubMed ID: 29991969
[TBL] [Abstract][Full Text] [Related]
9. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.
Pucić M; Knezević A; Vidic J; Adamczyk B; Novokmet M; Polasek O; Gornik O; Supraha-Goreta S; Wormald MR; Redzić I; Campbell H; Wright A; Hastie ND; Wilson JF; Rudan I; Wuhrer M; Rudd PM; Josić D; Lauc G
Mol Cell Proteomics; 2011 Oct; 10(10):M111.010090. PubMed ID: 21653738
[TBL] [Abstract][Full Text] [Related]
10. Sialylation of anti-histone immunoglobulin G autoantibodies determines their capabilities to participate in the clearance of late apoptotic cells.
Magorivska I; Muñoz LE; Janko C; Dumych T; Rech J; Schett G; Nimmerjahn F; Bilyy R; Herrmann M
Clin Exp Immunol; 2016 Apr; 184(1):110-7. PubMed ID: 26618514
[TBL] [Abstract][Full Text] [Related]
11. Control of lupus activity during pregnancy via the engagement of IgG sialylation: novel crosstalk between IgG sialylation and pDC functions.
Wang Y; Lin S; Wu J; Jiang M; Lin J; Zhang Y; Ding H; Zhou H; Shen N; Di W
Front Med; 2023 Jun; 17(3):549-561. PubMed ID: 37010728
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunogenetic factors associated with pneumonia in patients with systemic lupus erythematosus: a case-control study.
Rúa-Figueroa I; Nóvoa J; García-Laorden MI; Erausquin C; García-Bello M; Rodríguez de Castro F; Herrera-Ramos E; Ojeda S; Quevedo JC; Francisco F; Naranjo A; Rodríguez-Lozano C; Rodríguez-Gallego C
J Rheumatol; 2014 Sep; 41(9):1801-7. PubMed ID: 25086072
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.
Nehring J; Schirmbeck LA; Friebus-Kardash J; Dubler D; Huynh-Do U; Chizzolini C; Ribi C; Trendelenburg M
Front Immunol; 2018; 9():2090. PubMed ID: 30333817
[No Abstract] [Full Text] [Related]
14. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
[TBL] [Abstract][Full Text] [Related]
16. Profile of Immunoglobulin G
Hou H; Yang H; Liu P; Huang C; Wang M; Li Y; Zhu M; Wang J; Xu Y; Wang Y; Ma Q; Li D; Liao P; Wang W
Front Immunol; 2021; 12():748566. PubMed ID: 34630427
[TBL] [Abstract][Full Text] [Related]
17. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.
Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC
J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.
Rondaan C; van Leer CC; van Assen S; Bootsma H; de Leeuw K; Arends S; Bos NA; Westra J
Lupus; 2018 Jul; 27(8):1271-1278. PubMed ID: 29667858
[TBL] [Abstract][Full Text] [Related]
19. IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?
Lood C; Allhorn M; Lood R; Gullstrand B; Olin AI; Rönnblom L; Truedsson L; Collin M; Bengtsson AA
Arthritis Rheum; 2012 Aug; 64(8):2698-706. PubMed ID: 22392566
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
